Description
Cerebrolysin Concentrate Solution for Injections 215.2 mg/ml. 5 ml. Ampoules №5
Ingredients
The main active ingredient in this product is Cerebrolysin. Each ampoule contains 215.2 mg/ml of Cerebrolysin.
Mechanism of Action
Cerebrolysin exerts its therapeutic effects through neurotrophic regulation, neuroprotection, and neurorepair mechanisms. It enhances neuronal metabolism, improves synaptic connectivity, and modulates neurotransmitter release.
Pharmacological Properties
Cerebrolysin’s pharmacological properties include promoting neuronal survival, enhancing neuroplasticity, and reducing neuroinflammation. It also stimulates the production of neurotrophic factors and supports brain tissue regeneration.
Indications for Use
Cerebrolysin is indicated for the treatment of various neurological conditions, including Alzheimer’s disease, stroke, and traumatic brain injuries. It is also beneficial in cognitive disorders and vascular dementia.
Contraindications
Cerebrolysin is contraindicated in patients with known hypersensitivity to the active ingredient. It should not be used in individuals with acute kidney diseases, severe renal impairment, or a history of anaphylactic reactions to similar products.
Side Effects
Common side effects of Cerebrolysin may include mild injection site reactions, gastrointestinal disturbances, and transient flu-like symptoms. Rarely, allergic reactions or hypersensitivity manifestations may occur.
Usage Instructions
Cerebrolysin should be administered intravenously or intramuscularly under healthcare provider supervision. The general recommended dosage is one ampoule per day, adjusted based on the patient’s condition severity and response to treatment. Do not alter the dosage without medical advice.
Benefits Compared to Analogues
Cerebrolysin stands out from other neurotrophic agents due to its multi-targeted neuroprotective actions, superior efficacy in enhancing cognitive function, and well-established safety profile. It offers a comprehensive approach to neurological disorders management.
Suitable Patient Groups
Cerebrolysin can be used in a wide range of patient groups, including adults of all ages, elderly individuals experiencing cognitive decline, and patients with neurological deficits. It is not recommended for use in children without medical supervision.
Storage and Shelf Life
Store Cerebrolysin in a cool, dry place away from direct sunlight. Do not freeze. Check the expiration date on the packaging and do not use the product if expired. Once opened, use the ampoule immediately and discard any unused portion.
Packaging Description
Cerebrolysin is available in 5 ml ampoules containing 215.2 mg/ml of the active ingredient. The packaging is designed to maintain product integrity and sterility. Each box contains 5 ampoules for single-use.
